New consortium will monitor safety/efficacy of COVID-19 vaccines
The move provides the opportunity to conduct essential post-marketing surveillance
Read More
Tag: safety
Public unaware of how to verify legitimacy of online pharmacies, survey finds
Millions of people in the UK could be putting their health at risk because they do not know how to check the safety of medicines they bought online, suggest findings of a new survey.
Read More
Europe recalling some valsartan meds on safety fears
The European Medicines Agency is reviewing medicines containing valsartan supplied by a facility in China after a potentially cancer-causing impurity was detected.
Read More
Biogen, AbbVie pull MS drug from the market
European regulators have started an “urgent review” of Biogen and Abbvie’s multiple sclerosis therapy Zinbryta following a stream of cases of serious inflammatory brain disorders in patients taking the drug.
Read More
CQC to rate health websites and non-NHS services
The Care Quality Commission is to get new powers to award quality ratings to wider range of healthcare services, including websites for medical advice and prescriptions from GPs online.
Read More
EU safety review backs continued use Uptravi for PAH
European regulators have ruled that Actelion’s Uptravi can continue to be used as per its prescribing information to treat patients with pulmonary arterial hypertension, a life-threatening condition involving abnormally high blood pressure in the arteries of the lungs.
Read More
CQC takes action against web pharmacies
The Care Quality Commission has taken action against four online pharmacies after concluding that their services were posing a risk to patient safety.
Read More
NHS on ‘burning platform’, warns chief hospital inspector
Professor Sir Mike Richards, the Care Quality Commission’s chief inspector, has warned that the NHS is standing on a “burning platform”, and that the model of acute care that once worked well “cannot continue to meet the needs of today’s population”.
Read More
EU regulators allow use of Uptravi during safety review
European regulators are advising that doctors can continue prescribing Actelion’s Uptravi for pulmonary arterial hypertension while an investigation into its safety is completed.
Read More
Statin harms exaggerated, finds major review
A comprehensive review of the efficacy and safety of statins, based on 30 years’ research and published in The Lancet, has concluded that the therapy’s benefits have been underestimated and harms exaggerated.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
